[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100527157":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":53,"collaborators":56,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":26,"eligibilityCriteria":64,"healthyVolunteers":65,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":26,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":78,"overallStatus":84,"whyStopped":26,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Konkuk University Medical Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"cryoprecipitate","ACTIVE_COMPARATOR","If serum-fibrinogen \\\u003C 100 mg\u002Fdl or CFF-MA \\\u003C 15 mm in thromboelastography (TEG), cryoprecipitate is administered",[13],"Biological: fresh frozen plasma",{"label":15,"type":16,"description":17,"interventionNames":18},"fibirnogen concentrate","EXPERIMENTAL","If serum-fibrinogen \\\u003C 80 mg\u002Fdl or CFF-MA \\\u003C 15 mm in thromboelastography (TEG), fibrinogen concentrate is administered.",[19],"Biological: prothrombin complex concentrate",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"BIOLOGICAL","fresh frozen plasma","transfusion of fresh frozen plasma",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"prothrombin complex concentrate","prothrombin complex concentrate administration",[15],[32],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"Tae-Yop Kim, MD PhD","CONTACT","+82-10-8811-6942","taeyop@gmail.com",[38],{"facility":39,"status":26,"city":40,"state":26,"zip":26,"country":41,"countryCode":26,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Samsung Medical Center","Seoul","South Korea",{"type":43,"coordinates":44},"Point",[45,46],126.9784,37.566,{"lat":46,"lon":45},[49],{"name":50,"role":34,"phone":51,"phoneExt":26,"email":52},"Yu Jeong Bang, MD, PhD","+821051758275","gagreflex.bang@gmail.com",{"type":54,"investigatorFullName":33,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Professor of Anesthesiology",[57],{"name":39,"class":6},"100527157","phase-4-fibrinogen-concentrates-versus-cryoprecipitate-in-liver-transplant-surgery-100527157",false,"NCT06144112","Fibrinogen Concentrates Versus Cryoprecipitate in Liver Transplant Surgery","A Randomized Trial Comparing the Time for Managing Intraoperative Hypofibrinogenemia Using Fibrinogen Concentrates Versus Cryoprecipitate in Liver Transplant Surgery (FIBCRYO-LT Trial)","Inclusion Criteria:\n\n* Liver disease undergoing Liver transplantation\n\nExclusion Criteria:\n\n\\-",true,"ALL","20 Years","75 Years",{"count":70,"type":71},92,"ESTIMATED","INTERVENTIONAL",[74],"PHASE4","We compared the time consumed for goal-directed management of hypofibrinogemia using two strategies during liver transplant (LT) surgery: a conventional cryoprecipitate-based strategy versus a lyophilized fibrinogen concentrate-based strategy",[77],"Liver Diseases",[79,80,81,9,82,83],"hypofirinogenemia","coagulopathy","fibrinogen","liver transplantation","lyophilized factor concentrates","NOT_YET_RECRUITING","2025-07-16",{"date":87,"type":88},"2025-07-20","ACTUAL",{"date":90,"type":71},"2025-09-01",{"date":92,"type":71},"2026-03-31",{"name":5,"class":6},1]